India is the 4th largest medical devices market in Asia after Japan, China, and South Korea. It is poised to grow as a market worth USD 50 billion by 2025. Nearly 70–80% of the Indian medical device market is highly dependent on imports.
As a populous country, India provides manufacturers with promising opportunities owing to increasing healthcare demands. However, accessing the Indian market is prone to significant hurdles with dynamic Regulatory requirements.
To minimize setbacks from unforeseen hurdles and accelerate access to the Indian market, the registrants must keep up with anticipated CDSCO Regulatory changes and collaborate with Regulatory experts.
